Community actions
-
Holding
-
Recently bought
-
Recently sold
Merck & Co., Inc. news
-
Bristol-Myers' Orencia Gets Breakthrough Therapy Tag for GvHD
-
J&J Stock Witnesses Volatility in '19: What to Expect in 2020
-
Biotech Stock Roundup: Pipeline Updates From BIIB, AXSM, CARA, Collaborations & More
-
Roche's Tecentriq-Chemo Combo Gets FDA Nod in First-Line NSCLC
-
Pfizer/Astellas Xtandi Gets Nod in China for Prostate Cancer (Revised)
-
Merck Cyberattack’s $1.3 Billion Question: Was It an Act of War?
-
Seattle Genetics, Astellas Tie Up With Merck for Cancer Study
Recent Motivations
-
Douglas NordSold11 shares of
-
Setting limit order on Merk which is trading at much higher multiple then BMY. Look to move out with price fluctuations.
-
-
Douglas NordBought11 shares of
-
Another company that has very promising immunotherapy drugs for an er treatment like BMY.
-
-
Daniel TruesdaleBought4 shares of
-
I needed a pretty stable investment
-
-
Riley MSold1 shares of
-
.
-
-
Riley MBought2 shares of